Screening Strategies for Molecular Glue Discovery
Molecular glues are molecules that can encourage two proteins to interact when they otherwise may not. As a consequence, they...
Continue Reading
Molecular glues are molecules that can encourage two proteins to interact when they otherwise may not. As a consequence, they...
Continue Reading
Antibody-targeted therapies—including antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), and degrader-antibody conjugates (DACs)—are reshaping precision medicine by enabling highly selective delivery...
Continue Reading
Antibody-drug conjugates (ADCs) hold great promise as cancer therapeutics, as they combine the precision of monoclonal antibodies with the potency...
Continue Reading
Gene therapies are enabling a rapid expansion in the scope of treatable disease. Adeno-associated viruses (AAVs) are particularly advantageous delivery...
Continue Reading
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific...
Continue Reading
Designing effective oligonucleotide therapeutics for clinical applications involves understanding both the chemistry and biology of nucleic acids. In this white...
Continue Reading
Download our whitepaper on how using biophysical techniques can enhance and streamline processes throughout the drug discovery and validation cycle....
Continue Reading